Insiders · PRME

PRME insider transactions

Prime Medicine Inc. (PRME) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PRME

• 8d
  SEC Form 4 filed by Makhni Svetlana Ni

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 8d
  SEC Form 3 filed by new insider Makhni Svetlana Ni

  3 - Prime Medicine, Inc. (0001894562) (Issuer)
• 57d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 60d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 60d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 263d
  Large owner Gv 2021 Gp, L.L.C. bought $4,950,000 worth of shares (1,500,000 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 267d
  Director Nelsen Robert bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 267d
  Large owner Arch Venture Partners Xii, Llc bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 267d
  Large owner Arch Venture Partners X, Llc bought $9,999,990 worth of shares (3,030,300 units at $3.30) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 298d
  Large owner Liu David R. bought $52,830 worth of shares (21,000 units at $2.52), increasing direct ownership by 0.10% to 20,240,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 306d
  Large owner Liu David R. bought $45,402 worth of shares (21,000 units at $2.16), increasing direct ownership by 0.10% to 20,219,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 313d
  Large owner Liu David R. bought $31,196 worth of shares (21,000 units at $1.49), increasing direct ownership by 0.10% to 20,198,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 317d
  Large owner Liu David R. bought $33,590 worth of shares (21,000 units at $1.60), increasing direct ownership by 0.10% to 20,177,945 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 324d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 338d
  Chief Business Officer Brudnick Richard bought $23,790 worth of shares (20,000 units at $1.19) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 338d
  Chief Technical Officer Lee Ann L. bought $113,000 worth of shares (100,000 units at $1.13) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 338d
  Chief Executive Officer Reine Allan bought $147,150 worth of shares (125,000 units at $1.18) (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 341d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 341d
  SEC Form 4 filed by Chief Executive Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 348d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 348d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 348d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 417d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by Officer Alenson Carman

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by SVP, Strategy & Corporate Ops. Goldwasser Meredith

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by Chief Scientific Officer Duffield Jeremy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by Chief Technical Officer Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by Chief Business Officer Brudnick Richard

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 418d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 502d
  SEC Form 4 filed by Officer Gottesdiener Keith Michael

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 502d
  SEC Form 4 filed by Chief Business Officer Brudnick Richard

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 502d
  SEC Form 4 filed by Chief Financial Officer Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 562d
  Officer Gottesdiener Keith Michael gifted 226,925 shares and received a gift of 226,925 shares (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Marrazzo Jeffrey D

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Schenkein David P

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Foster-Cheek Kaye I

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Chung Wendy

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Kelly Michael Aaron

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 680d
  SEC Form 4 filed by Director Cahill Thomas

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 687d
  Gottesdiener Keith Michael gifted 250,000 shares and received a gift of 250,000 shares, decreasing direct ownership by 10% to 2,310,837 units (SEC Form 4)

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 704d
  SEC Form 4 filed by Reine Allan

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 704d
  SEC Form 4 filed by Brudnick Richard

  4 - Prime Medicine, Inc. (0001894562) (Issuer)
• 704d
  SEC Form 4 filed by Lee Ann L.

  4 - Prime Medicine, Inc. (0001894562) (Issuer)